While correction in share prices was justified for many of these stocks, some, such as Affirm (NASDAQ: AFRM) and CrowdStrike (NASDAQ: CRWD), seem to have been excessively punished despite solid business models and healthy financials. Investors are increasingly worried about the effects of high and sticky inflation, supply chain constraints, labor shortages, and the pace of global economic recovery. In December 2021, the Consumer Financial Protection Bureau (CFPB) launched an inquiry into the practices of five BNPL players, including Affirm.